Pharming PHAR
NASDAQ PHAR
$9.75 -0.23 (-2.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Price to Earnings (2021 - 2026)

Updated

Pharming's (PHAR) Price to Earnings stood at 70.47 in Q2 2026, down 55.5% from the prior quarter.

Analysis

Pharming (PHAR) Price to Earnings (2021 - 2026) Analysis & Trends

For FY2025, Pharming's Price to Earnings came in at 427.54.

  • Across earlier years, Price to Earnings came in at 30.87 in FY2022 (+9.9%) and 28.09 in FY2021 (+139.3%).
  • The Q2 2026 figure is the lowest quarterly Price to Earnings since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Pharming 698.17 Mn -131.99 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.47
Mar 31, 2026 158.21
Dec 31, 2025 427.54
Dec 31, 2022 52.84
Sep 30, 2022 42.52
Jun 30, 2022 101.60
Mar 31, 2022 275.40
Dec 31, 2021 81.48
Sep 30, 2021 12.31
Jun 30, 2021 12.34
API Access

Pharming Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PHAR&period=max&api_key=YOUR_API_KEY